Abstract
SummaryRabbit antimeningococcus immune sera as well as commercial therapeutic sera in high dilutions protect mice against infection with virulent meningococci. In comparatively low dilution they exert a favorable action on the course of the experimental infection even when administered relatively late in its course. The mouse protection test is regarded as a more reasonable method than those at present employed for the standardization of therapeutic antimeningococcus sera.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
